HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Is Associated With Endothelial Dysfunction.

AbstractOBJECTIVE:
Endothelial dysfunction is an initial step in atherosclerotic cardiovascular disease. However, involvement of vascular inflammation in endothelial dysfunction is not fully investigated in humans because of the lack of diagnostic modality to noninvasively evaluate vascular inflammation. We assessed the relationship between endothelial function and vascular inflammation evaluated by [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomographic imaging.
APPROACH AND RESULTS:
We examined endothelial function and vascular inflammation by flow-mediated dilation (FMD) of the brachial artery and [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomographic imaging of carotid arteries, respectively, in 145 subjects (95 men and 50 women; mean age, 61.8±9.5 years) who underwent a risk-screening test for cardiovascular disease in Kurume University Hospital. Vascular inflammation was measured by blood-normalized standardized uptake value, known as a target:background ratio (TBR). We investigated whether absolute changes from baseline of %FMD after antihypertensive treatment for 6 months (Δ%FMD) were correlated with those of TBR in 33 drug-naive patients with essential hypertension. Multiple logistic regression analysis revealed that age (odds ratio, 1.767 for 10-year increase), male sex (odds ratio, 0.434), low-density lipoprotein-cholesterol (odds ratio, 1.630 for 26-mg/dL increase), and TBR values (odds ratio, 1.759 for 0.2 increase) were independently associated with %FMD in 145 patients. There was an inverse correlation between Δ%FMD and ΔTBR; ΔTBR was a sole independent associate of Δ%FMD in hypertensive patients (r=-0.558; P<0.001).
CONCLUSIONS:
The present study showed that vascular inflammation in the carotid arteries evaluated by [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomography was one of the independent correlates of decreased %FMD, thus suggesting the association of vascular inflammation with endothelial dysfunction in humans.
AuthorsAkihiro Honda, Nobuhiro Tahara, Yoshikazu Nitta, Atsuko Tahara, Sachiyo Igata, Munehisa Bekki, Tomohisa Nakamura, Yoichi Sugiyama, Hayato Kaida, Seiji Kurata, Kiminori Fujimoto, Toshi Abe, Mika Enomoto, Hisashi Adachi, Jagat Narula, Sho-Ichi Yamagishi, Yoshihiro Fukumoto
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 36 Issue 9 Pg. 1980-8 (09 2016) ISSN: 1524-4636 [Electronic] United States
PMID27386941 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2016 American Heart Association, Inc.
Chemical References
  • Antihypertensive Agents
  • Biomarkers
  • Cholesterol, LDL
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
Topics
  • Aged
  • Antihypertensive Agents (therapeutic use)
  • Biomarkers (blood)
  • Brachial Artery (diagnostic imaging, drug effects, physiopathology)
  • Carotid Artery Diseases (diagnostic imaging, physiopathology)
  • Carotid Intima-Media Thickness
  • Cholesterol, LDL (blood)
  • Endothelium, Vascular (diagnostic imaging, drug effects, physiopathology)
  • Female
  • Fluorodeoxyglucose F18 (administration & dosage)
  • Humans
  • Hypertension (diagnostic imaging, drug therapy, physiopathology)
  • Japan
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Positron Emission Tomography Computed Tomography
  • Predictive Value of Tests
  • Radiopharmaceuticals (administration & dosage)
  • Regional Blood Flow
  • Risk Factors
  • Sex Factors
  • Time Factors
  • Treatment Outcome
  • Vasculitis (diagnostic imaging, physiopathology)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: